CVS Health Co. (NYSE:CVS) Stock Holdings Decreased by Capital City Trust Co. FL

Capital City Trust Co. FL decreased its stake in shares of CVS Health Co. (NYSE:CVSFree Report) by 6.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 30,171 shares of the pharmacy operator’s stock after selling 2,046 shares during the period. Capital City Trust Co. FL’s holdings in CVS Health were worth $2,382,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Live Oak Investment Partners acquired a new position in shares of CVS Health in the 4th quarter worth approximately $25,000. Atticus Wealth Management LLC lifted its stake in CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the last quarter. Cornerstone Planning Group LLC increased its stake in CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 243 shares during the last quarter. PCA Investment Advisory Services Inc. acquired a new stake in shares of CVS Health during the second quarter worth $37,000. Finally, ZRC Wealth Management LLC lifted its position in shares of CVS Health by 400.0% in the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after buying an additional 400 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

Shares of NYSE CVS opened at $79.76 on Friday. CVS Health Co. has a 1 year low of $64.41 and a 1 year high of $83.25. The firm has a market cap of $100.37 billion, a P/E ratio of 12.35, a PEG ratio of 1.05 and a beta of 0.51. The stock has a fifty day moving average price of $75.91 and a two-hundred day moving average price of $73.58. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86.

CVS Health (NYSE:CVSGet Free Report) last announced its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The business had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. During the same quarter last year, the business posted $1.99 earnings per share. The company’s quarterly revenue was up 11.9% on a year-over-year basis. Research analysts forecast that CVS Health Co. will post 8.33 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.34%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio is presently 41.18%.

Analyst Ratings Changes

CVS has been the topic of several research reports. StockNews.com lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Piper Sandler increased their price target on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. HSBC started coverage on CVS Health in a research report on Friday, December 22nd. They set a “buy” rating and a $94.00 price objective for the company. SVB Leerink began coverage on CVS Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $88.00 target price on the stock. Finally, Royal Bank of Canada lowered their price target on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research report on Thursday, February 8th. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $90.21.

Check Out Our Latest Report on CVS Health

Insider Buying and Selling

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.25% of the stock is currently owned by insiders.

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.